Solutions for Pharmaceutical and Biotechnology Companies
Enhance Efficiency, Improve Trial Outcomes, and Accelerate Market Entry
Leverage TrialKey’s cutting-edge AI technology to revolutionise your clinical development processes. From protocol design to trial execution, we empower you to create data-driven strategies that streamline operations, optimise recruitment, and maximise the probability of regulatory and commercial success. With over three decades of clinical trial data and proprietary machine learning that utilise Natural Language Processing (NLP) algorithms, we empower pharmaceutical sponsors to execute trials that are scientifically robust, operationally efficient, and strategically aligned with market demands.
Featured In
Key Advantages of TrialKey’s Biostatistical Validation
Unmatched Data Precision
30+ Years of Global Trial Data
TrialKey processes vast datasets from both structured and unstructured sources, ensuring every insight is backed by historical trends, competitor data, and trial benchmarks.
AI-Powered Simulations for Protocol Success
We leverage machine learning to simulate trial outcomes, helping you refine endpoints, minimise risks, and design protocols with a high probability of success.
Real-Time Competitive Insights
Competitor Benchmarking
See how your trial design stacks up against competitors in the same therapeutic area, with comparisons on success probabilities and best practices.
Unstructured Data Analysis
Extract hidden insights from unstructured sources, including trial announcements and global registries, with NLP-driven analysis that traditional platforms miss.
Patient-Centric Trial Optimisation
Tailored Recruitment Strategies
Get targeted recommendations on which countries, number of sites, and number of patient touchpoints.
Inclusion/Exclusion Criteria Refinement
Increase enrolment success with AI-driven adjustments to eligibility criteria, enhancing statistical power and reducing delays.
Our Partners
Key Features Designed for Industry Leaders
AI-Driven Protocol Optimisation
- Inclusion/Exclusion Criteria Refinement: Utilise AI-backed statistical models to optimise eligibility criteria, enhancing enrolment efficiency without compromising scientific rigour.
- Endpoint Validation: Design primary and secondary endpoints with precision, aligning with regulatory and clinical efficacy benchmarks.
- Dynamic Trial Simulations: Generate over 100,000 predictive scenarios for each trial, ensuring statistically validated designs with the highest probability of success.
Comprehensive Competitive Landscape Analysis
- Comparative Benchmarking: Position your trial protocol against global competitors using proprietary data visualisations and success metrics.
- Therapeutic Area Intelligence: Leverage insights into trial density, competing protocols, and standard of care within your indication.
- Technology Mapping: Identify cutting-edge methodologies and innovations influencing trial outcomes in your therapeutic domain.
Advanced Reporting for Strategic Decisions
- Preliminary Report: Delivered within five business days, these concise yet data-rich reports support RFP submissions with visual insights into success probabilities, competitor comparisons, and optimised protocols.
- In-Depth Report: These reports provide comprehensive, actionable insights to enhance trial success rates, optimise resource allocation, and accelerate market entry. These reports include detailed analyses of trial design, patient selection criteria, study arms, duration, and competitor benchmarking, all tailored to the specific goals of the trial.
The TrialKey Advantage for Pharmaceutical Sponsors
Biostatistical Excellence
- Harness insights from over 468,000 trials, spanning 114,925 conditions and 2.69 billion patients.
- Employ AI-driven simulations to model trial success with over 92% accuracy, reducing costly amendments and protocol deviations.
Seamless Integration with CROs or Internal Teams
- Collaborate with your preferred CRO or internal clinical operations team to implement TrialKey’s data-driven recommendations across the trial lifecycle.
- Improve operational efficiency with transparent workflows and compliance-aligned methodologies.
Optimised Regulatory Outcomes
- Enhance submission readiness by integrating real-world evidence and biostatistical validation directly into protocols.
Your Competitive Edge in Clinical Development
With an industry-wide trial failure rate of over 90% in pivotal studies, TrialKey mitigates risk by:
- Proactively identifying design vulnerabilities.
- Providing actionable intelligence for resource optimisation.
- Offering visual data narratives to enhance stakeholder buy-in.
Proven Compliance and Partnership Transparency
As a publicly listed company, Opyl follows strict ASX compliance standards, ensuring transparency in every partnership and major contract.
Customised ASX Announcements
For each partnership, we create tailored ASX disclosures covering financial terms, project scope, and duration, ensuring all parties remain fully informed.Collaborative Communications
Key project updates are shared in standalone announcements or quarterly reports, based on the project scope and mutual agreement.
Partner with TrialKey
Join leading pharmaceutical companies in leveraging TrialKey’s transformative AI platform to de-risk development pipelines, streamline clinical operations, and accelerate market entry for life-saving therapies.
